Biomarker in Lung Diseases

Heidelberg University

Status: Unknown

Conditions: Lung Diseases

Treatments: Other: biomarker

Study type: Observational

Funder types: Other

Identifiers

NCT00989846

MK02

Details and patient eligibility

About

Disease related biomarkers have been established decades ago, e.g. blood glucose for diabetes diagnosis and management. Their discovery has grown dramatically during the past decade and they have the potential to lead the physician in diagnosis -especially differential diagnosis - and therapy.

However, a specific serum-biomarker in lung diseases has not been established. Aim of the current study is to to measure lung specific proteins in the serum in patients with various lung diseases and to correlate those with disease severity, lung function and other laboratory results

Enrollment: 120 estimated patients

Sex: All

Ages: 18 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• age >= 18
• acute or chronic lung disease

Exclusion criteria

• HIV
• lactation or gestation

Trial design

120 participants in 1 patient group

lung disease

Description:

patients with various chronic or acute lung diseases

Treatment:

Other: biomarker